Featured Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar Ongoing trials like SELECT that are aimed at CV outcomes “will certainly change the cardiovascular disease landscape,” says Sean Heffron. By L.A. McKeown May 12, 2023
News Conference News ESOC 2023 TESLA Falls Short, But Experts Still See Role for EVT in Large-Core Strokes
News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year